HTA5 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Panama
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1139
https://www.valueinhealthjournal.com/article/S1098-3015(22)01340-7/fulltext
Title :
HTA5 Cost-Utility Analysis of Dapagliflozin in Patients with Chronic Kidney Disease in Panama
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01340-7&doi=10.1016/j.jval.2022.04.1139
First page :
Section Title :
Open access? :
No
Section Order :
11016